News | Congenital Heart | October 03, 2022

Memorial Cardiac and Vascular Institute Battling Heart Disease in a New Place

The new ECHO lab enables cardiac teams to use ultrasound (or echocardiography) to assess the size and efficiency of heart chambers. Stress tests, coronary CTAs, and cardiac MRIs are also interpreted there. 

The new ECHO lab enables cardiac teams to use ultrasound (or echocardiography) to assess the size and efficiency of heart chambers. Stress tests, coronary CTAs, and cardiac MRIs are also interpreted there.

October 3, 2022 — A new ‘ECHO lab’ at Memorial Hospital West is benefiting patients that may have heart disease and the cardiac specialists that treat them. 

The space enables cardiac teams to use ultrasound (or echocardiography) to assess the size and efficiency of heart chambers. This non-invasive, outpatient test also allows for assessment of blood flow through the heart valves to determine if there is narrowing, backflow, or other issues that prevent optimal function. Stress tests, coronary CTAs, and cardiac MRIs are also interpreted there. “Our cardiac teams were involved in the design of the ECHO lab and were able to maximize use of the space,” said Dr. Omosalewa Adewale, medical director of cardiac imaging at Memorial Cardiac and Vascular Institute

Congenital heart disease, cardiomyopathy, infective endocarditis, pericardial disease, and rheumatic heart disease are just a few of the ailments that can be diagnosed through echocardiographic testing. It can also determine how other diseases, including cancer and stroke, have affected the heart’s function. 

Memorial’s cardiac sonographers, cardiology fellowship trainees, and cardiologists all collaborate to interpret imaging tests that influence treatment decisions. 

The Memorial Cardiac & Vascular Institute is a cardiovascular care leader, offering a wide array of services dedicated to the prevention, detection, and treatment of cardiovascular disease. Its multi-disciplinary specialists collaborate using sophisticated diagnostic equipment and facilities. Cardiovascular care outcomes are regularly reviewed by physician-review panels and nurses to ensure quality assurance that utilizes computerized data collection. 

For more information: mhs.net/services/cardiac-vascular 


Related Content

News | Heart Failure

April 16, 2024 — Each year more than 500,000 Americans undergo percutaneous coronary intervention, or PCI, a minimally ...

Home April 16, 2024
Home
News | Heart Failure

April 12, 2024 — University of Virginia School of Medicine researchers have discovered a gene on the Y chromosome that ...

Home April 12, 2024
Home
News | Heart Failure

April 2, 2024 — People who use e-cigarettes are significantly more likely to develop heart failure compared with those ...

Home April 02, 2024
Home
News | Heart Failure

March 29, 2024 — V-Wave announced it will present late-breaking data from its RELIEVE-HF pivotal trial at the American ...

Home March 29, 2024
Home
News | Heart Failure

March 25, 2024 — A team of engineers led by the University of Massachusetts Amherst and including colleagues from the ...

Home March 25, 2024
Home
News | Heart Failure

March 15, 2024 — BioCardia, Inc. , a biotechnology company focused on advancing late-stage cell therapy interventions ...

Home March 15, 2024
Home
News | Heart Failure

March 15, 2024 — BioCardia, Inc., a biotechnology company focused on advancing late-stage cell therapy interventions for ...

Home March 15, 2024
Home
News | Heart Failure

March 13, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home March 13, 2024
Home
News | Heart Failure

March 8, 2024 — The Texas Heart Institute, Georgia Institute of Technology (Georgia Tech), North Carolina State ...

Home March 08, 2024
Home
News | Heart Failure

March 5, 2024 — FIRE1 announced that it has completed patient enrollment in the U.S. Early Feasibility Study (FUTURE-HF2 ...

Home March 05, 2024
Home
Subscribe Now